Results 41 to 50 of about 49,350 (169)
Clinical Pharmacology &Therapeutics, EarlyView.We evaluated whether concomitant 5‐aminosalicylic acid (5‐ASA) influences clinical remission in patients with ulcerative colitis (UC) receiving Janus kinase inhibitors (JAKi). In this retrospective, multicenter cohort study, UC patients receiving tofacitinib (n = 181), upadacitinib (n = 313), or filgotinib (n = 139) were included.
Antonio Tursi +100 more
wiley +1 more source
Association of Chronic Diseases With Herpes Zoster in China: A Nationwide Population‐Based Survey
Health Care Science, EarlyView.Chronic disease was associated with elevated herpes zoster risk (aOR = 1.84, 95% CI: 1.51–2.24). Among 14 chronic conditions, heart disease showed the strongest association (aOR = 2.91, 95% CI: 2.07–4.10), followed by diabetes (aOR = 2.04, 95% CI: 1.48–2.80) and hypertension (aOR = 1.89, 95% CI: 1.47–2.42).
Wenhui Zhu +10 more
wiley +1 more source
Rare Occurrence of Herpes Zoster of Trigeminal Nerve following Extraction of Tooth
Case Reports in Dentistry, 2015 Herpes Zoster also known as Shingles is an acute viral infection which is an extremely painful and incapacitating ailment. It results from the reactivation of the varicella zoster virus.
A. Winnifred Christy +3 more
doaj +1 more source
Journal of Pediatric Gastroenterology and Nutrition, EarlyView.Abstract Objectives Tofacitinib is a selective Janus kinase (JAK‐1) inhibitor approved for the treatment of ulcerative colitis (UC) in adults. Data is limited in the pediatric population. The aim of this study was to evaluate the efficacy of tofacitinib in pediatric inflammatory bowel disease (IBD).
Denise D. Young +10 more
wiley +1 more source
Efficacy of upadacitinib induction for pediatric inflammatory bowel disease
JPGN Reports, EarlyView.Abstract Objectives Upadacitinib, a second‐generation Janus kinase (JAK) inhibitor, is approved for moderate to severe Crohn's disease (CD) and ulcerative colitis (UC) in adults. Its efficacy in pediatric patients remains unclear, though early reports suggest benefits in refractory inflammatory bowel disease (IBD).
Evan Greenhall +5 more
wiley +1 more source
Zhongguo gonggong weishengObjectiveTo systematically evaluate the pharmacoeconomic research on herpes zoster (HZ) vaccine administration, providing reference for related research and prevention of HZ.
Xinping LIU +4 more
doaj +1 more source
Herpes zoster in an immunocompetent adolescent – A case of rare occurrence
Journal of Family Medicine and Primary CareHerpes zoster is an acute viral infection caused by the reactivation of the varicella zoster virus. It occurs commonly in immunocompromised adults. Odontalgia may be an early prodromal symptom when herpes zoster involves the oral and maxillofacial region,
A.Winnifred Christy +3 more
doaj +1 more source
Herpes zoster: Epidemiological Features of the Incidence in 2019
Эпидемиология и вакцинопрофилактика, 2020 The urgency of the problem of herpes zoster (shingles) consists in its wide distribution in the world, high incidence rates in a significant part of the subjects of the Russian Federation, as well as the severity of complications caused by this infection.
A. N. Kaira, V. F. Lavrov
doaj +1 more source
The Kaohsiung Journal of Medical Sciences, EarlyView.ABSTRACT This trial was to evaluate the efficacy and the safety of colchicine for the palliative treatment of patients with primary hepatic malignancy unable to receive curative treatment. Forty hepatocellular carcinoma (HCC) patients and two intrahepatic cholangiocarcinoma (ICC) patients signed the informed consents.
Zu‐Yau Lin +8 more
wiley +1 more source
Construction of risk prediction model for postherpetic neuralgia of patients with herpes zoster
Huli yanjiu, 2022 ObjectiveTo analyze the risk factors of postherpetic neuralgia（PHN） of patients with herpes zoster and to construct risk prediction model.Methods425 patients with herpes zoster admitted to department of dermatology of our hospital were selected as study ...
LI Jiao, HUANG Guohui, NI Ping
doaj